losartan has been researched along with IgA Vasculitis in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
IgA Vasculitis: A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bosch, X | 1 |
Brouard, M | 1 |
Piguet, V | 1 |
Chavaz, P | 1 |
Borradori, L | 1 |
2 other studies available for losartan and IgA Vasculitis
Article | Year |
---|---|
Henoch-Schönlein purpura induced by losartan therapy.
Topics: Antihypertensive Agents; Humans; IgA Vasculitis; Losartan; Male; Middle Aged | 1998 |
Schönlein-Henoch purpura associated with losartan treatment and presence of antineutrophil cytoplasmic antibodies of x specificity.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Female; Humans; IgA Vasculiti | 2001 |